Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Bevacizumab Versus Intravitreal Triamcinolone Acetonide for Refractory Diabetic Macular Edema

NCT00468351 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT00468351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00468351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Bevacizumab Versus Intravitreal Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Lead sponsor
University of Sao Paulo
Phase
Phase 1
Overall status
Unknown status
Start date
April 30, 2006
Completion date
April 30, 2007
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema